N-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide

C34H39N5O8 — CID 71025030

IUPACN-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide
SMILESCN(C)c1cc(NC(=O)C2CN(Cc3ccccc3)C2)c(O)c2c1CC1C[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]3(O)C(=O)C1=C2O
InChIInChI=1S/C34H39N5O8/c1-37(2)22-12-21(36-33(46)18-14-39(15-18)13-16-8-6-5-7-9-16)27(40)24-19(22)10-17-11-20-26(38(3)4)29(42)25(32(35)45)31(44)34(20,47)30(43)23(17)28(24)41/h5-9,12,17-18,20,26,40-41,44,47H,10-11,13-15H2,1-4H3,(H2,35,45)(H,36,46)/t17?,20-,26-,34-/m0/s1
InChIKeyUEFNGSXLRFAYIH-ZXZNDWAQSA-N
MW645.71 g/mol
LogP1.10
Rot. Bonds7

About N-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide

N-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide (PubChem CID 71025030) has the molecular formula C34H39N5O8 and a molecular weight of 645.71 g/mol. Its IUPAC name is N-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide.

Molecular Properties

Compound NameN-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide
PubChem CID71025030
Molecular FormulaC34H39N5O8
Molecular Weight645.71 g/mol
Exact Mass645.28
IUPAC NameN-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide
SMILESCN(C)c1cc(NC(=O)C2CN(Cc3ccccc3)C2)c(O)c2c1CC1C[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]3(O)C(=O)C1=C2O
InChIInChI=1S/C34H39N5O8/c1-37(2)22-12-21(36-33(46)18-14-39(15-18)13-16-8-6-5-7-9-16)27(40)24-19(22)10-17-11-20-26(38(3)4)29(42)25(32(35)45)31(44)34(20,47)30(43)23(17)28(24)41/h5-9,12,17-18,20,26,40-41,44,47H,10-11,13-15H2,1-4H3,(H2,35,45)(H,36,46)/t17?,20-,26-,34-/m0/s1
InChIKeyUEFNGSXLRFAYIH-ZXZNDWAQSA-N
XLogP1.10
TPSA196.97 Ų
H-Bond Donors6
H-Bond Acceptors11
Rotatable Bonds7
Heavy Atoms47
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500645.71
LogP ≤ 51.10
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'catechol', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_4', 'substructure': 'N/A'}

Analyze N-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide?
The IUPAC name of N-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide (CID 71025030) is N-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide.
What is the SMILES notation for N-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide?
The canonical SMILES for N-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide is CN(C)c1cc(NC(=O)C2CN(Cc3ccccc3)C2)c(O)c2c1CC1C[C@H]3[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]3(O)C(=O)C1=C2O.
What is the InChIKey of N-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide?
The InChIKey is UEFNGSXLRFAYIH-ZXZNDWAQSA-N. The full InChI is InChI=1S/C34H39N5O8/c1-37(2)22-12-21(36-33(46)18-14-39(15-18)13-16-8-6-5-7-9-16)27(40)24-19(22)10-17-11-20-26(38(3)4)29(42)25(32(35)45)31(44)34(20,47)30(43)23(17)28(24)41/h5-9,12,17-18,20,26,40-41,44,47H,10-11,13-15H2,1-4H3,(H2,35,45)(H,36,46)/t17?,20-,26-,34-/m0/s1.
What are the key properties of N-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide?
N-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide has a molecular weight of 645.71 g/mol, XLogP of 1.10, 7 rotatable bonds, 6 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(6aS,7S,10aR)-9-carbamoyl-4,7-bis(dimethylamino)-1,10,10a,12-tetrahydroxy-8,11-dioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-1-benzylazetidine-3-carboxamide is sourced from PubChem (CID 71025030), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).